skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Accumulation of D- vs. L-isomers of alanine and leucine in rat prostatic adenocarcinoma

Conference · · J. Nucl. Med.; (United States)
OSTI ID:6853465

It has been reported that tumor tissue may accumulate some D-amino acids preferentially over the L-isomers. In order to investigate the potential use of carbon-11 labeled amino acid isomers for in vivo tumor studies with positron emission tomography in patients, the tissue distributions of alanine and leucine, substrates for the A-type and L-type amino acid transport systems, respectively, were studied in Copenhagen rates bearing the Dunning R3327G prostatic adenocarcinoma. The authors have previously reported differences in the accumulation of A-type vs. L-type amino acids in rat prostatic adenocarcinoma and normal tissues. All compounds were labeled with C-14 in the carboxyl position with specific activities of 30.0-56.6 mCi/mmol. Higher levels of C-14 activity (Relative Concentration (RC)=dpm found per gm tissue + dpm inject per gm animal mass) were observed in tumor tissue using D-alanine (0.71) compared to L- (0.21) or DL-alanine (0.27) at 45 min post-injection. While tumor/prostate and tumor/liver ratios were above 2 for all three substrates, tumor/blood and tumor/muscle were above one for only the D-isomer. Comparisons made with D-, L-, and DL-leucine also demonstrated a higher level of RC in tumor tissue with the D-isomer (0.84) vs. the L-(0.66) and DL-leucine (0.63). In this case, however, tumor/blood, tumor/prostate, and tumor/muscle ratios were above one for all three substrates, while tumor/liver ratios were below one. These results support the observation of a preferential accumulation of D-amino acids in tumor tissue over the natural L-isomers. Observed differences in the accumulation of the isomers in normal tissues are discussed.

Research Organization:
Memorial Sloan-Kettering Cancer Center, New York, NY 10021
OSTI ID:
6853465
Report Number(s):
CONF-850611-; TRN: 87-010917
Journal Information:
J. Nucl. Med.; (United States), Vol. 26:5; Conference: 32. annual meeting of the Society of Nuclear Medicine, Houston, TX, USA, 2 Jun 1985
Country of Publication:
United States
Language:
English

Similar Records

Development of (/sup 11/C)-. cap alpha. -aminoisobutyric acid and (/sup 18/F)-haloperidol as substrate-specific radiotracers
Thesis/Dissertation · Fri Jan 01 00:00:00 EST 1982 · OSTI ID:6853465

Affinity of $sup 253$Es for tumour tissue
Journal Article · Thu Nov 01 00:00:00 EST 1973 · Nature (London) New Biol., v. 246, no. 149, pp. 23-25 · OSTI ID:6853465

A potential use of Indium-111 labeled monocytes as a tumor imaging agent
Conference · Sun Jan 01 00:00:00 EST 1984 · J. Nucl. Med.; (United States) · OSTI ID:6853465